Prevention of thromboembolic complications in patients with superficial-vein thrombosis given rivaroxaban or fondaparinux: the open-label, randomised, non-inferiority SURPRISE phase 3b trial

Jan Beyer‐Westendorf, Sebastian Schellong, H. Gerlach, Eberhard Rabe, Jeffrey I. Weitz, Katja Jersemann, Kurtuluş Şahin, Rupert Bauersachs

The Lancet Haematology · 2017 · 171 citations · 11 references

Concepts

References

11